Journal articles on the topic 'Insulin resistance'

To see the other types of publications on this topic, follow the link: Insulin resistance.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Insulin resistance.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kumar, Sinha Ritesh, and Chandra Satish. "Insulin resistance." Asian Pacific Journal of Health Sciences, Supplimentary 2014 (2014): 71–78. http://dx.doi.org/10.21276/apjhs.2014.1.1s.15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sowers, James R., and Edward D. Frohlich. "Insulin and insulin resistance:." Medical Clinics of North America 88, no. 1 (January 2004): 63–82. http://dx.doi.org/10.1016/s0025-7125(03)00128-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jeffery, Alison. "Insulin resistance." Nursing Standard 17, no. 32 (April 23, 2003): 47–53. http://dx.doi.org/10.7748/ns2003.04.17.32.47.c3381.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Tomono, Syouichi. "Insulin Resistance :." Kitakanto Medical Journal 62, no. 1 (2012): 73–74. http://dx.doi.org/10.2974/kmj.62.73.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jeffery, Alison. "Insulin resistance." Nursing Standard 17, no. 32 (April 23, 2003): 47–55. http://dx.doi.org/10.7748/ns.17.32.47.s62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Park, Kyong Soo. "Insulin Resistance." Journal of the Korean Medical Association 44, no. 3 (2001): 302. http://dx.doi.org/10.5124/jkma.2001.44.3.302.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bell, David S. H. "Insulin resistance." Postgraduate Medicine 93, no. 7 (May 15, 1993): 99–107. http://dx.doi.org/10.1080/00325481.1993.11701704.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Carroll, P. B., and R. C. Eastman. "Insulin Resistance." Endocrinologist 1, no. 2 (April 1991): 89–97. http://dx.doi.org/10.1097/00019616-199104000-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

DeFronzo, Ralph A. "Insulin resistance." Current Opinion in Cardiology 5, no. 5 (October 1990): 592–98. http://dx.doi.org/10.1097/00001573-199010000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Whitelaw, D. C., and S. G. Gilbey. "Insulin Resistance." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 35, no. 5 (September 1998): 567–83. http://dx.doi.org/10.1177/000456329803500501.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Sinaiko, Alan R., and Sonia Caprio. "Insulin Resistance." Journal of Pediatrics 161, no. 1 (July 2012): 11–15. http://dx.doi.org/10.1016/j.jpeds.2012.01.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

VOLL, ARTUR, and JOHAN KLOSTER. "Insulin Resistance." Acta Medica Scandinavica 157, no. 3 (April 24, 2009): 223–32. http://dx.doi.org/10.1111/j.0954-6820.1957.tb14430.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

El Ray, Ahmed, Tarik Asselah, Rami Moucari, Maged El Ghannam, Alaa A. Taha, Mohamed A. Saber, Maha Akl, et al. "Insulin resistance." European Journal of Gastroenterology & Hepatology 25, no. 4 (April 2013): 421–27. http://dx.doi.org/10.1097/meg.0b013e32835c9f69.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

O'Doherty, R., D. Stein, and J. Foley. "Insulin resistance." Diabetologia 40 (September 19, 1997): S10—S15. http://dx.doi.org/10.1007/s001250051389.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

El-Zayadi, Abdel-Rahman. "Insulin resistance." Arab Journal of Gastroenterology 11, no. 2 (June 2010): 66–69. http://dx.doi.org/10.1016/j.ajg.2010.04.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Altunoglu, Esma Guldal. "Insulin resistance." Istanbul Medical Journal 13, no. 3 (2012): 0. http://dx.doi.org/10.5505/1304.8503.2012.78941.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Krenkel, Jessica A. "Insulin Resistance." Topics in Clinical Nutrition 17, no. 5 (December 2002): 85. http://dx.doi.org/10.1097/00008486-200212000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Nesbitt, Alexander. "Insulin Resistance." Journal of Advanced Nursing 44, no. 3 (October 20, 2003): 327–28. http://dx.doi.org/10.1046/j.1365-2648.2003.02826_3.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Wolfrum, C., E. Asilmaz, E. Luca, J. M. Friedman, and M. Stoffel. "Insulin Resistance." Journal of the American Society of Nephrology 16, no. 3 (March 2005): 569–71. http://dx.doi.org/10.1681/01.asn.0000926692.88991.55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Chaoji, Sunanda Ashutosh. "Insulin Resistance." Vidarbha Journal of Internal Medicine 33 (April 6, 2023): 27–31. http://dx.doi.org/10.25259/vjim_41_2022.

Full text
Abstract:
The twin epidemic of ‘Diabesity’-diabetes and obesity, all over the world, both in developed and developing countries, has brought the issue of insulin resistance (IR) into new focus of research. Apart from Type 2 diabetes mellitus (DM), IR is implicated in many other clinical syndromes because of its varied metabolic and mitogenic actions. IR has been found to play important pivotal role in pathophysiology of diabesity. IR is defined as when a normal or higher insulin level fails to produce expected biological response; one predominantly affecting insulin mediated glucose disposal 20–30% reduction in the number of insulin receptors on the target cells is observed in majority of Type 2 DM patients but 1/3 of the patients may not manifest loss of number of receptors; therefore, defective post-receptor signalling is considered as the main cause of IR. Main sites of IR are liver, adipose tissue and skeletal muscles. Apart from Type 2 DM, many other clinical and genetic syndromes are associated with IR.
APA, Harvard, Vancouver, ISO, and other styles
21

O’Doherty, R., D. Stein, and J. Foley. "Insulin resistance." Diabetologia 40, S3 (March 1997): B10—B15. http://dx.doi.org/10.1007/bf03168180.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Perkins, Amanda. "Insulin resistance." Nursing Made Incredibly Easy! 22, no. 3 (April 10, 2024): 5–13. http://dx.doi.org/10.1097/nme.0000000000000046.

Full text
Abstract:
Insulin resistance is believed to be a precursor to type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disease. Through education, nurses can understand their role in helping patients manage this condition.
APA, Harvard, Vancouver, ISO, and other styles
23

Beale, Elmus G. "Insulin Signaling and Insulin Resistance." Journal of Investigative Medicine 61, no. 1 (January 1, 2013): 11–14. http://dx.doi.org/10.2310/jim.0b013e3182746f95.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

OʼHare, James A. "Insulin, insulin resistance, and hypertension." Current Opinion in Endocrinology and Diabetes 1, no. 1 (January 1994): 147–52. http://dx.doi.org/10.1097/00060793-199400010-00027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Stumvoll, Michael, and Hans Häring. "Insulin Resistance and Insulin Sensitizers." Hormone Research in Paediatrics 55, no. 2 (2001): 3–13. http://dx.doi.org/10.1159/000063466.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

HOWARD, BARBARA V. "Insulin, Insulin Resistance, and Dyslipidemia." Annals of the New York Academy of Sciences 683, no. 1 Dietary Lipid (June 1993): 1–8. http://dx.doi.org/10.1111/j.1749-6632.1993.tb35687.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Petersen, Max C., and Gerald I. Shulman. "Mechanisms of Insulin Action and Insulin Resistance." Physiological Reviews 98, no. 4 (October 1, 2018): 2133–223. http://dx.doi.org/10.1152/physrev.00063.2017.

Full text
Abstract:
The 1921 discovery of insulin was a Big Bang from which a vast and expanding universe of research into insulin action and resistance has issued. In the intervening century, some discoveries have matured, coalescing into solid and fertile ground for clinical application; others remain incompletely investigated and scientifically controversial. Here, we attempt to synthesize this work to guide further mechanistic investigation and to inform the development of novel therapies for type 2 diabetes (T2D). The rational development of such therapies necessitates detailed knowledge of one of the key pathophysiological processes involved in T2D: insulin resistance. Understanding insulin resistance, in turn, requires knowledge of normal insulin action. In this review, both the physiology of insulin action and the pathophysiology of insulin resistance are described, focusing on three key insulin target tissues: skeletal muscle, liver, and white adipose tissue. We aim to develop an integrated physiological perspective, placing the intricate signaling effectors that carry out the cell-autonomous response to insulin in the context of the tissue-specific functions that generate the coordinated organismal response. First, in section II, the effectors and effects of direct, cell-autonomous insulin action in muscle, liver, and white adipose tissue are reviewed, beginning at the insulin receptor and working downstream. Section III considers the critical and underappreciated role of tissue crosstalk in whole body insulin action, especially the essential interaction between adipose lipolysis and hepatic gluconeogenesis. The pathophysiology of insulin resistance is then described in section IV. Special attention is given to which signaling pathways and functions become insulin resistant in the setting of chronic overnutrition, and an alternative explanation for the phenomenon of ‟selective hepatic insulin resistanceˮ is presented. Sections V, VI, and VII critically examine the evidence for and against several putative mediators of insulin resistance. Section V reviews work linking the bioactive lipids diacylglycerol, ceramide, and acylcarnitine to insulin resistance; section VI considers the impact of nutrient stresses in the endoplasmic reticulum and mitochondria on insulin resistance; and section VII discusses non-cell autonomous factors proposed to induce insulin resistance, including inflammatory mediators, branched-chain amino acids, adipokines, and hepatokines. Finally, in section VIII, we propose an integrated model of insulin resistance that links these mediators to final common pathways of metabolite-driven gluconeogenesis and ectopic lipid accumulation.
APA, Harvard, Vancouver, ISO, and other styles
28

Chandra, Nimai Chand. "Hyperlipidimia, Hyperleptinemia and Insulin Resistance Intercorrelation with Obesity." Diabetes & Obesity International Journal 5, no. 1 (2020): 1–6. http://dx.doi.org/10.23880/doij-16000223.

Full text
Abstract:
The present study has shown a parallel increase of triacylglycerol, cholesterol, and low density lipoprotein (LDL) along with an increase in body mass and BMI of human obese subjects. Conversely a fall in HDL concentration was observed. Plasma leptin level increased proportionately with increase of body weight as obesity advanced from obese to morbid type. A positive correlation was observed between leptin and insulin concentrations in obese subjects. A parallel increase of plasma glucose concentration was followed with decreased expression of insulin receptor, measured in adipose tissue, with the progress of obesity. The decreased insulin receptor concentration might be the reason for seen insulin resistance and increased insulin level which marked the positive correlation with associated liptin level in obese subjects.
APA, Harvard, Vancouver, ISO, and other styles
29

Zhang, Li, Tao Liu, Pei-Yong Zheng, and Guang Ji. "Leptin resistance and insulin resistance." World Chinese Journal of Digestology 17, no. 15 (2009): 1534. http://dx.doi.org/10.11569/wcjd.v17.i15.1534.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Sivitz, William I. "Understanding insulin resistance." Postgraduate Medicine 116, no. 1 (July 2004): 41–48. http://dx.doi.org/10.3810/pgm.2004.07.1550.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

SARUTA, TAKAO. "Insulin resistance syndrome." Nihon Naika Gakkai Zasshi 85, no. 2 (1996): 285–91. http://dx.doi.org/10.2169/naika.85.285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Bloomgarden, Z. T. "Insulin Resistance Concepts." Diabetes Care 30, no. 5 (April 27, 2007): 1320–26. http://dx.doi.org/10.2337/dc07-zb05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Fletcher, Barbara, and Cindy Lamendola. "Insulin Resistance Syndrome." Journal of Cardiovascular Nursing 19, no. 5 (September 2004): 339–45. http://dx.doi.org/10.1097/00005082-200409000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Leslie, M. "Outfoxing Insulin Resistance." Science of Aging Knowledge Environment 2002, no. 36 (September 11, 2002): 125nw—125. http://dx.doi.org/10.1126/sageke.2002.36.nw125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Polonsky, William. "Psychological Insulin Resistance." Diabetes Educator 33, no. 7s (July 2007): 241S—244S. http://dx.doi.org/10.1177/0145721707305701.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Montminy, Marc, and Seung-Hoi Koo. "Outfoxing insulin resistance?" Nature 432, no. 7020 (December 2004): 958–59. http://dx.doi.org/10.1038/432958a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Funnell, Martha Mitchell. "Understanding insulin resistance." Nursing 42, no. 3 (March 2012): 62. http://dx.doi.org/10.1097/01.nurse.0000411421.44527.bf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Cheng, Tsung O. "Insulin Resistance Syndrome." Southern Medical Journal 91, no. 7 (July 1998): 697. http://dx.doi.org/10.1097/00007611-199807000-00041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

GRANBERRY, MARK C., and VIVIAN A. FONSECA. "Insulin Resistance Syndrome." Southern Medical Journal 92, no. 1 (January 1999): 2–14. http://dx.doi.org/10.1097/00007611-199901000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Cummings, Doyle M., Sarah Henes, Kathryn M. Kolasa, John Olsson, and David Collier. "Insulin Resistance Status." Archives of Pediatrics & Adolescent Medicine 162, no. 8 (August 1, 2008): 764. http://dx.doi.org/10.1001/archpedi.162.8.764.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

DeFronzo, Ralph A. "Introduction: Insulin Resistance." Diabetes / Metabolism Reviews 5, no. 5 (August 1989): iii. http://dx.doi.org/10.1002/dmr.5610050505.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Willette, Auriel A., Christine M. Burns, and Barbara B. Bendlin. "Insulin Resistance andAPOEε4." JAMA Neurology 72, no. 12 (December 1, 2015): 1536. http://dx.doi.org/10.1001/jamaneurol.2015.3285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Jeffery, Alison. "Prepubertal insulin resistance." Practical Diabetes 29, no. 4 (May 2012): 130–31. http://dx.doi.org/10.1002/pdi.1676.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Limoncini, A., C. Smirne, F. Corliano, C. Marconi, E. Scaglia, G. Carnevale, P. Toniutto, C. Fabris, and M. Pirisi. "[725] INSULIN RESISTANCE, INSULIN SECRETION AND." Journal of Hepatology 46 (April 2007): S273. http://dx.doi.org/10.1016/s0168-8278(07)62323-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

MAGSINO, CESAR H., and JUDY SPENCER. "Insulin Receptor Antibodies and Insulin Resistance." Southern Medical Journal 92, no. 7 (July 1999): 717–19. http://dx.doi.org/10.1097/00007611-199907000-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Gallagher, Emily Jane, and Derek LeRoith. "Insulin, Insulin Resistance, Obesity, and Cancer." Current Diabetes Reports 10, no. 2 (March 6, 2010): 93–100. http://dx.doi.org/10.1007/s11892-010-0101-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Adiga, Usha, Kathyayani P, and Nandith P.B. "Association of Insulin Based Insulin Resistance with Liver Biomarkers in Type 2 Diabetes mellitus." Journal of Pure and Applied Microbiology 13, no. 2 (June 30, 2019): 1199–205. http://dx.doi.org/10.22207/jpam.13.2.60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Chitturi, Shivakumar, Shehan Abeygunasekera, Geoffrey C. Farrell, Jane Holmes-Walker, Jason M. Hui, Caroline Fung, Rooshdiya Karim, et al. "NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome." Hepatology 35, no. 2 (February 2002): 373–79. http://dx.doi.org/10.1053/jhep.2002.30692.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Pollak, Michael N. "Insulin, insulin-like growth factors, insulin resistance, and neoplasia." American Journal of Clinical Nutrition 86, no. 3 (September 1, 2007): 820S—822S. http://dx.doi.org/10.1093/ajcn/86.3.820s.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Lin, Hua V., Ja-Young Kim, Alessandro Pocai, Luciano Rossetti, Lawrence Shapiro, Philipp E. Scherer, and Domenico Accili. "Adiponectin Resistance Exacerbates Insulin Resistance in Insulin Receptor Transgenic/Knockout Mice." Diabetes 56, no. 8 (May 2, 2007): 1969–76. http://dx.doi.org/10.2337/db07-0127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography